At an FDA Anesthetic and Analgesic Drug Products Advisory Committee meeting, the Committee voted eight against, and seven in favor of, the approval of Trevena’s oliceridine drug for the management of moderate to severe acute pain in adult patients for whom an intravenous (IV) opioid is warranted.  “We continue to believe that the totality of evidence presented and…